Location: San Diego, CA
CIK: 0001232621 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $679M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | 1,950,609 | $39.68M | 5.8% | $20.34 | $21.51 | -5.7% | COM | 032724106 |
| TARS | TARSUS PHARMACEUTICALS INC | 1,779,158 | $32.15M | 4.7% | $18.07 * | $15.51 | +2.5% | COM | 87650L103 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,137,107 | $29.42M | 4.3% | $25.87 * | $21.51 | +23.6% | COM | 604749101 |
| — | IMMUNOGEN INC | 1,300,000 | $24.53M | 3.6% | $18.87 | $7.64 | — | COM | 45253H101 |
| IMCR | IMMUNOCORE HLDGS PLC | 405,600 | $24.32M | 3.6% | $59.96 | $30.74 | — | ADS | 45258D105 |
| — | BLUEBIRD BIO INC | 7,382,827 | $24.29M | 3.6% | $3.29 | $3.78 | — | COM | 09609G100 |
| KALV | KALVISTA PHARMACEUTICALS INC | 2,651,393 | $23.86M | 3.5% | $9.00 * | $9.23 | -0.1% | COM | 483497103 |
| AXSM | AXSOME THERAPEUTICS INC | 320,000 | $23M | 3.4% | $71.86 * | $57.63 | +28.0% | COM | 05464T104 |
| EOLS | EVOLUS INC | 3,097,399 | $22.52M | 3.3% | $7.27 * | $8.75 | -1.4% | COM | 30052C107 |
| — | INTRA-CELLULAR THERAPIES INC | 300,000 | $19M | 2.8% | $63.32 | $59.78 | — | COM | 46116X101 |
| — | NEW YORK CMNTY BANCORP INC | 1,606,600 | $18.06M | 2.7% | $11.24 | $9.04 | — | COM | 649445103 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 2,450,000 | $17.25M | 2.5% | $7.04 * | $9.70 | -17.3% | COM | 09058V103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 692,925 | $16.48M | 2.4% | $23.79 * | $15.92 | +61.1% | COM | 92790C104 |
| ONC | BEIGENE LTD | 85,000 | $15.16M | 2.2% | $178.30 | $134.82 | — | SPONSORED ADR | 07725L102 |
| PCVX | VAXCYTE INC | 300,000 | $14.98M | 2.2% | $49.94 * | $39.24 | +20.8% | COM | 92243G108 |
| LLY | LILLY ELI & CO | 30,000 | $14.07M | 2.1% | $468.98 * | $340.49 | +20.8% | COM | 532457108 |
| IFRX | INFLARX NV | 2,900,000 | $12.93M | 1.9% | $4.46 | $4.48 | 0.0% | COM | N44821101 |
| AZN | ASTRAZENECA PLC | 170,000 | $12.17M | 1.8% | $71.57 | $56.36 | — | SPONSORED ADR | 046353108 |
| CTMX | CYTOMX THERAPEUTICS INC | 6,600,000 | $11.35M | 1.7% | $1.72 * | $1.89 | -12.2% | COM | 23284F105 |
| AVIR | ATEA PHARMACEUTICALS INC | 3,026,455 | $11.32M | 1.7% | $3.74 | $3.85 | -2.7% | COM | 04683R106 |
| BCAB | BIOATLA INC | 3,674,076 | $11.02M | 1.6% | $3.00 * | $6.57 | -47.7% | COM | 09077B104 |
| ALT | ALTIMMUNE INC | 2,750,000 | $9.707M | 1.4% | $3.53 * | $9.59 | -53.2% | COM NEW | 02155H200 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 271,200 | $9.544M | 1.4% | $35.19 | $41.60 | -17.0% | COM | 413197104 |
| ZYME | ZYMEWORKS DEL INC | 1,100,000 | $9.504M | 1.4% | $8.64 * | $8.10 | +10.5% | COM | 98985Y108 |
| MRNA | MODERNA INC | 76,700 | $9.319M | 1.4% | $121.50 * | $164.11 | -18.7% | COM | 60770K107 |
| COF | CAPITAL ONE FINL CORP | 80,000 | $8.75M | 1.3% | $109.37 * | $99.69 | -3.8% | COM | 14040H105 |
| — | THIRD HARMONIC BIO INC | 1,800,000 | $8.658M | 1.3% | $4.81 | $4.29 | — | COM | 88427A107 |
| VSTM | VERASTEM INC | 1,140,000 | $8.482M | 1.2% | $7.44 * | $6.94 | 0.0% | COM NEW | 92337C203 |
| — | AMARIN CORP PLC | 7,100,000 | $8.449M | 1.2% | $1.19 | $1.43 | — | SPONS ADR NEW | 023111206 |
| — | KINIKSA PHARMACEUTICALS LTD | 600,000 | $8.448M | 1.2% | $14.08 | $9.90 | — | COM CL A | G5269C101 |
| IONS | IONIS PHARMACEUTICALS INC | 200,000 | $8.206M | 1.2% | $41.03 * | $32.73 | +17.4% | COM | 462222100 |
| — | ELEVATION ONCOLOGY INC | 4,000,000 | $6.08M | 0.9% | $1.52 | $1.54 | — | COM | 28623U101 |
| BIO | BIO RAD LABS INC | 16,000 | $6.066M | 0.9% | $379.12 * | $570.32 | -28.6% | CL A | 090572207 |
| — | ADICET BIO INC | 2,479,552 | $6.025M | 0.9% | $2.43 | $6.52 | — | COM | 007002108 |
| QNCX | QUINCE THERAPEUTICS INC | 3,613,280 | $5.438M | 0.8% | $1.50 * | $0.98 | +59.1% | COM | 22053A107 |
| — | GRAPHITE BIO INC | 2,085,625 | $5.423M | 0.8% | $2.60 | $2.61 | — | COM | 38870X104 |
| CGEM | CULLINAN ONCOLOGY INC | 450,000 | $4.842M | 0.7% | $10.76 | $11.56 | -8.1% | COM | 230031106 |
| ADMA | ADMA BIOLOGICS INC | 1,260,000 | $4.649M | 0.7% | $3.69 | $3.71 | 0.0% | COM | 000899104 |
| C | CITIGROUP INC | 100,000 | $4.604M | 0.7% | $46.04 * | $44.28 | -3.5% | COM NEW | 172967424 |
| — | MAGENTA THERAPEUTICS INC | 6,060,000 | $4.593M | 0.7% | $0.76 | $0.79 | — | COM | 55910K108 |
| PYXS | PYXIS ONCOLOGY INC | 1,787,775 | $4.577M | 0.7% | $2.56 * | $1.97 | +60.8% | COMMON STOCK | 747324101 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 4,887,238 | $4.521M | 0.7% | $0.92 | $0.92 | — | SPONDS ADR | 00653A107 |
| — | RAIN ONCOLOGY INC | 3,740,341 | $4.488M | 0.7% | $1.20 | $1.20 | — | COM | 75082Q105 |
| GNFTY | GENFIT S A | 1,234,436 | $4.37M | 0.6% | $3.54 | $4.75 | — | ADS | 372279109 |
| — | BOLT BIOTHERAPEUTICS INC | 3,333,803 | $4.267M | 0.6% | $1.28 | $1.37 | — | COM | 097702104 |
| — | ENZO BIOCHEM INC | 2,300,000 | $4.232M | 0.6% | $1.84 | $2.43 | — | COM | 294100102 |
| NVCR | NOVOCURE LTD | 100,000 | $4.15M | 0.6% | $41.50 * | $62.09 | 0.0% | ORD SHS | G6674U108 |
| — | ASLAN PHARMACEUTICALS LTD | 1,128,068 | $4.117M | 0.6% | $3.65 | $2.88 | — | SPON ADS NEW | 04522R200 |
| — | DYNAVAX TECHNOLOGIES CORP | 300,000 | $3.876M | 0.6% | $12.92 | $10.57 | — | COM NEW | 268158201 |
| — | VERITEX HLDGS INC | 210,000 | $3.765M | 0.6% | $17.93 | $18.10 | — | COM | 923451108 |
| GLPG | GALAPAGOS NV | 89,650 | $3.645M | 0.5% | $40.66 | $62.02 | — | SPON ADR | 36315X101 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 250,000 | $3.58M | 0.5% | $14.32 * | $11.53 | 0.0% | COM | 71722W107 |
| — | PARDES BIOSCIENCES INC | 1,945,206 | $3.521M | 0.5% | $1.81 | $1.75 | — | COM | 69945Q105 |
| INSM | INSMED INC | 166,203 | $3.507M | 0.5% | $21.10 * | $23.98 | -20.9% | COM PAR $.01 | 457669307 |
| BHVN | BIOHAVEN LTD | 140,000 | $3.349M | 0.5% | $23.92 * | $14.12 | +21.9% | COM | G1110E107 |
| FATE | FATE THERAPEUTICS INC | 700,000 | $3.332M | 0.5% | $4.76 * | $6.03 | -8.5% | COM | 31189P102 |
| USB | US BANCORP DEL | 100,000 | $3.304M | 0.5% | $33.04 * | $28.41 | 0.0% | COM NEW | 902973304 |
| — | ALIGOS THERAPEUTICS INC | 3,329,048 | $3.233M | 0.5% | $0.97 | $1.06 | — | COM | 01626L105 |
| NKTX | NKARTA INC | 1,385,829 | $3.035M | 0.4% | $2.19 * | $11.10 | -60.4% | COM | 65487U108 |
| — | MIRATI THERAPEUTICS INC | 80,000 | $2.89M | 0.4% | $36.13 | $36.13 | — | COM | 60468T105 |
| SPRY | ARS PHARMACEUTICALS INC | 409,463 | $2.743M | 0.4% | $6.70 | $4.93 | +34.7% | COM | 82835W108 |
| CVBF | CVB FINL CORP | 200,000 | $2.656M | 0.4% | $13.28 * | $19.92 | -38.8% | COM | 126600105 |
| ESPR | ESPERION THERAPEUTICS INC NE | 1,850,000 | $2.571M | 0.4% | $1.39 | $5.16 | -73.0% | COM | 29664W105 |
| — | AVROBIO INC | 2,705,000 | $2.57M | 0.4% | $0.95 | $0.95 | — | COM | 05455M100 |
| — | 2SEVENTY BIO INC | 250,000 | $2.53M | 0.4% | $10.12 | $17.06 | — | COMMON STOCK | 901384107 |
| LITS | MEI PHARMA INC | 361,084 | $2.376M | 0.3% | $6.58 * | $4.94 | 0.0% | COM | 55279B301 |
| EGRX | EAGLE PHARMACEUTICALS INC | 118,857 | $2.311M | 0.3% | $19.44 * | $32.45 | -26.9% | COM | 269796108 |
| LIANY | LIANBIO | 962,022 | $2.193M | 0.3% | $2.28 | $2.19 | — | SPONSORED ADS | 53000N108 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 100,000 | $2.157M | 0.3% | $21.57 * | $35.49 | -23.9% | COM | 03237H101 |
| BKU | BANKUNITED INC | 100,000 | $2.155M | 0.3% | $21.55 * | $29.03 | -36.0% | COM | 06652K103 |
| HRTX | HERON THERAPEUTICS INC | 1,850,000 | $2.146M | 0.3% | $1.16 * | $4.36 | -59.1% | COM | 427746102 |
| — | EQUITY COMWLTH | 100,000 | $2.026M | 0.3% | $20.26 | $20.71 | — | COM SH BEN INT | 294628102 |
| ARVN | ARVINAS INC | 80,000 | $1.986M | 0.3% | $24.82 * | $37.14 | -30.8% | COM | 04335A105 |
| CHRS | COHERUS BIOSCIENCES INC | 400,000 | $1.708M | 0.3% | $4.27 * | $9.57 | -38.3% | COM | 19249H103 |
| EDIT | EDITAS MEDICINE INC | 200,000 | $1.646M | 0.2% | $8.23 * | $8.71 | 0.0% | COM | 28106W103 |
| AUPH | AURINIA PHARMACEUTICALS INC | 150,000 | $1.452M | 0.2% | $9.68 * | $10.38 | 0.0% | COM | 05156V102 |
| BOH | BANK HAWAII CORP | 30,000 | $1.237M | 0.2% | $41.23 * | $38.82 | 0.0% | COM | 062540109 |
| SFBS | SERVISFIRST BANCSHARES INC | 30,000 | $1.228M | 0.2% | $40.92 * | $63.35 | -30.7% | COM | 81768T108 |
| IVVD | INVIVYD INC | 1,151,843 | $1.209M | 0.2% | $1.05 * | $1.47 | -13.0% | COM | 00534A102 |
| CRSP | CRISPR THERAPEUTICS AG | 20,000 | $1.123M | 0.2% | $56.14 | $56.74 | 0.0% | NAMEN AKT | H17182108 |
| — | ATHIRA PHARMA INC | 352,715 | $1.041M | 0.2% | $2.95 | $3.17 | — | COM | 04746L104 |
| — | INSPIRATO INCORPORATED | 1,035,000 | $1.014M | 0.1% | $0.98 | $0.97 | — | COM CL A | 45791E107 |
| ASND | ASCENDIS PHARMA A/S | 10,000 | $893K | 0.1% | $89.25 | $89.25 | — | SPONSORED ADR | 04351P101 |
| — | NEXTCURE INC | 400,000 | $720K | 0.1% | $1.80 | $1.48 | — | COM | 65343E108 |
| MASS | 908 DEVICES INC | 100,000 | $686K | 0.1% | $6.86 * | $8.04 | 0.0% | COM | 65443P102 |
| TNGX | TANGO THERAPEUTICS INC | 200,000 | $664K | 0.1% | $3.32 * | $5.80 | -38.0% | COM | 87583X109 |
| PDSB | PDS BIOTECHNOLOGY CORP | 100,000 | $503K | 0.1% | $5.03 * | $6.55 | 0.0% | COM | 70465T107 |
| STEL | STELLAR BANCORP INC | 20,000 | $458K | 0.1% | $22.89 | $25.71 | -9.4% | COM | 858927106 |
| — | SELECTA BIOSCIENCES INC | 400,000 | $448K | 0.1% | $1.12 | $1.12 | — | COM | 816212104 |
| STIM | NEURONETICS INC | 200,000 | $430K | 0.1% | $2.15 * | $2.43 | 0.0% | COM | 64131A105 |
| WGS | GENEDX HOLDINGS CORP | 63,636 | $379K | 0.1% | $5.96 * | $7.91 | 0.0% | COM CL A | 81663L200 |
| ATYR | ATYR PHARMA INC | 150,000 | $324K | 0.0% | $2.16 | $5.31 | -58.9% | COM NEW | 002120202 |
| EQ | EQUILLIUM INC | 400,000 | $300K | 0.0% | $0.75 * | $0.73 | -9.0% | COM | 29446K106 |
| — | PASSAGE BIO INC | 300,000 | $282K | 0.0% | $0.94 | $0.96 | — | COM | 702712100 |
| — | FREELINE THERAPEUTICS HLDGS | 100,000 | $258K | 0.0% | $2.58 | $2.58 | — | SPONSORED ADS | 35655L206 |
| MOLN | MOLECULAR PARTNERS AG | 39,753 | $247K | 0.0% | $6.22 | $6.39 | — | ADS | 60853G106 |
| TLPH | ACELRX PHARMACEUTICALS INC | 195,000 | $216K | 0.0% | $1.11 * | $2.81 | -68.9% | COM NEW | 00444T209 |
| — | SMART POWERR CORP | 125,061 | $203K | 0.0% | $1.62 | $1.62 | — | COM | 168913309 |
| — | NEKTAR THERAPEUTICS | 139,600 | $80,298 | 0.0% | $0.58 | $5.39 | — | COM | 640268108 |